CLOMIPRAMINE HYDROCHLORIDE

Learn what this care may do. See what research says. Then check where to get care. A place may not be taking new patients.

Published Sep 19, 2026Revision 1 · EveryOptionen-US

identity

Clomipramine hydrochloride (Anafranil) is a prescription capsule medication whose retained U.S. labeling is indicated for obsessions and compulsions in patients with obsessive-compulsive disorder (OCD).

DailyMed clomipramine (Anafranil) label · checked Sep 18, 2026

Relationship: supports

Scope: country:US

Pointer: /sections/0

Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

Open source

why-linked

EveryOption links this treatment to OCD because the retained DailyMed Anafranil label Indications and Usage section states that Anafranil (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with OCD. That exact-pair claim was independently appraised as supported for the retained source record.

DailyMed clomipramine (Anafranil) label · checked Sep 18, 2026

Relationship: supports

Scope: country:US

Pointer: /sections/0

Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

Open source

indication-label

The retained Anafranil Indications and Usage labeling describes use for obsessions and compulsions in patients with OCD, including labeled effectiveness context for adults and for children and adolescents 10 to 17 years of age as stated on that label.

DailyMed clomipramine (Anafranil) label · checked Sep 18, 2026

Relationship: supports

Scope: country:US

Pointer: /sections/0

Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

Open source

scope

Product and population scope follows the retained capsule label context for patients with OCD whose obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with functioning, as labeled. This page does not establish dosing instructions, comparative effectiveness, or FDA approval status beyond what the retained Indications and Usage text supports. Access and availability are not shown here.

DailyMed clomipramine (Anafranil) label · checked Sep 18, 2026

Relationship: supports

Scope: country:US

Pointer: /sections/0

Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

Open source

provenance

Source: DailyMed (NLM) SPL label for Anafranil (clomipramine hydrochloride), SET 4074b555-7635-41a9-809d-fae3b3610059 version 22, Indications and Usage section. Attribution follows EveryOption’s adopted DailyMed editorial-use profile; NLM hosting is not a license grant.

DailyMed clomipramine (Anafranil) label · checked Sep 18, 2026

Relationship: supports

Scope: country:US

Pointer: /sections/0

Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

Open source

Published Need relationships

Select an exact Need to inspect its scoped research. Published conclusions appear first; uses without one follow under Not reviewed. This order is not a personal recommendation.

1 published use

Not reviewed

  • Obsessive-Compulsive Disorder

    DailyMed clomipramine (Anafranil) label · checked Sep 18, 2026

    Relationship: labeled indication

    Scope: country:US

    Pointer: /sections/0

    Supporting passage: Anafranil ™ (clomipramine hydrochloride) Capsules USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

    Open source

    Not reviewed

    No current published assessment exists for this exact Treatment and Need. This does not establish benefit or no benefit.

    Read exact answer

Next: check access

Research and local availability are different facts. Add a place to see known, source-backed access options for CLOMIPRAMINE HYDROCHLORIDE.

Find access

See something wrong? Tell us. Your note is private. We check sources before we change this page.